01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)
retatrutide safety trial Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 conducted in the USA ⚠️ BEWARE OF RETATRUTIDE SOLD
Description
While often bothersome, these reactions are typically mild and do not indicate that the medication is unsafe or ineffective
Conclusions This study offers reassurance in cases of inadvertent exposure to GLP1-RA during the first trimester of pregnancy
Brain-derived neurotrophic factor (BDNF) is a neuroprotective growth factor that supports neuronal proliferation, differentiation, and survival [12]
Also, on a more serious note, retatrutide raising your heart rate is annoying and mildly concerning
L.PetersonD
B-12 injections are sometimes associated with increased metabolism, which can aid in weight loss efforts
